Literature DB >> 16541934

Influence of asymmetry of vestibular caloric response and age on balance and perceived symptoms after acute unilateral vestibular loss.

Ann-Sofi C Kammerlind1, Torbjörn E A Ledin, Lars M Odkvist, Elisabeth I B Skargren.   

Abstract

OBJECTIVE: To evaluate the influence of asymmetry of vestibular caloric response and age on balance and perceived symptoms after acute unilateral vestibular loss.
DESIGN: Prospective study.
SETTING: Ear, nose and throat departments in three hospitals.
SUBJECTS: Fifty-four patients (mean age 52 years) with acute unilateral vestibular loss participating in a randomized controlled training study were included. MAIN MEASURES: Electronystagmography testing was performed within one week after onset of symptoms and after 10 weeks. The outcome measures clinical static balance tests (sharpened Romberg's test with eyes closed, standing on foam with eyes closed, and standing on one leg with eyes open and closed) and subjective symptom ratings on a visual analogue scale were done after one week, 10 weeks and six months. The correlation between age and asymmetry of vestibular caloric response, respectively, and the outcome measures were analysed.
RESULTS: Greater caloric asymmetry correlated with poorer performance at the sharpened Romberg's test and standing on one leg with eyes closed at all three follow-ups (rho = -0.31 to -0.54), and with higher symptom ratings at the 10-week and six-month follow-ups (rho = 0.30-0.60). Higher age was associated with poorer performance on the sharpened Romberg's test and standing on one leg at all three follow-ups (rho = 0.31-0.64), but did not change over time. Higher age was also associated with higher ratings of vertigo at the six-month follow-up, and less reduction of vertigo between the 10-week and six-month follow-ups (rho = 0.29-0.48).
CONCLUSIONS: A higher degree of asymmetry of vestibular caloric response and high age seem to be associated with poor outcome in balance and perceived symptoms after acute unilateral vestibular loss.

Entities:  

Mesh:

Year:  2006        PMID: 16541934     DOI: 10.1191/0269215506cr886oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Does betahistine treatment have additional benefits to vestibular rehabilitation?

Authors:  Hale Karapolat; Nese Celebisoy; Yesim Kirazli; Cem Bilgen; Sibel Eyigor; Sercan Gode; Aycan Akyuz; Tayfun Kirazli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-21       Impact factor: 2.503

2.  Cervical musculoskeletal, physical and psychological factors associated with ongoing dizziness in patients with whiplash associated disorder, 12 months after undertaking a neck specific or general exercise intervention.

Authors:  Julia Treleaven; Gunnel Peterson; Maria Landén Ludvigsson; Anneli Peolsson
Journal:  BMC Musculoskelet Disord       Date:  2022-07-18       Impact factor: 2.562

3.  Cross-cultural adaptation and validation of the Chinese version of the vestibular activities and participation measure.

Authors:  Peixia Wu; Mei Yang; Yan Hu; Huawei Li
Journal:  J Vestib Res       Date:  2019       Impact factor: 2.354

4.  Effects of neck-specific exercise with or without a behavioural approach in addition to prescribed physical activity for individuals with chronic whiplash-associated disorders: a prospective randomised study.

Authors:  Anneli Peolsson; Maria Landén Ludvigsson; Thomas Overmeer; Åsa Dedering; Lars Bernfort; Gun Johansson; Ann-Sofi Kammerlind; Gunnel Peterson
Journal:  BMC Musculoskelet Disord       Date:  2013-10-30       Impact factor: 2.362

5.  Neck-specific training with a cognitive behavioural approach compared with prescribed physical activity in patients with cervical radiculopathy: a protocol of a prospective randomised clinical trial.

Authors:  Åsa Dedering; Marie Halvorsen; Joshua Cleland; Mikael Svensson; Anneli Peolsson
Journal:  BMC Musculoskelet Disord       Date:  2014-08-12       Impact factor: 2.362

6.  Rehabilitation to improve gaze and postural stability in people with multiple sclerosis: study protocol for a prospective randomized clinical trial.

Authors:  Brian J Loyd; Annie Fangman; Daniel S Peterson; Eduard Gappmaier; Michael C Schubert; Anne Thackery; Lee Dibble
Journal:  BMC Neurol       Date:  2019-06-10       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.